119 related articles for article (PubMed ID: 33879470)
1. Clinical and pathological risk factors for worse stage and mortality of eyelid and periocular squamous cell carcinoma.
Luo Y; Chen H; Ge S; Rao Y; Yu J; Fan X; Jia R; Xu S; Wang Y
Br J Ophthalmol; 2022 Oct; 106(10):1338-1343. PubMed ID: 33879470
[TBL] [Abstract][Full Text] [Related]
2. Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma.
Xu S; Sagiv O; Rubin ML; Sa HS; Tetzlaff MT; Nagarajan P; Ning J; Esmaeli B
JAMA Ophthalmol; 2019 May; 137(5):537-542. PubMed ID: 30869769
[TBL] [Abstract][Full Text] [Related]
3. Diffuse pattern, orbital invasion, perineural invasion and Ki-67 are associated with nodal metastasis in patients with eyelid sebaceous carcinoma.
Gu X; Xie M; Luo Y; Song X; Xu S; Fan X
Br J Ophthalmol; 2023 Jun; 107(6):756-762. PubMed ID: 35063931
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients.
Sa HS; Rubin ML; Xu S; Ning J; Tetzlaff M; Sagiv O; Kandl TJ; Esmaeli B
Br J Ophthalmol; 2019 Jul; 103(7):980-984. PubMed ID: 30131380
[TBL] [Abstract][Full Text] [Related]
5. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma.
Faustina M; Diba R; Ahmadi MA; Esmaeli B
Ophthalmology; 2004 Oct; 111(10):1930-2. PubMed ID: 15465559
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual.
Ford J; Thakar S; Thuro B; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2017; 33(5):317-324. PubMed ID: 28350693
[TBL] [Abstract][Full Text] [Related]
7. Novel MSH6 mutation predicted metastasis in eyelid and periocular squamous cell carcinoma.
Luo Y; Rao Y; Gu X; Chai P; Yang Y; Lin J; Xu X; Jia R; Xu S
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):2331-2342. PubMed ID: 35855666
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological characteristics and clinical course of eyelid squamous cell carcinoma patients from a large tertiary centre between 2009 and 2020.
Klingenstein A; Samel C; Messmer EM; Garip-Kuebler A; Priglinger SG; Hintschich CR
Br J Ophthalmol; 2022 Aug; 106(8):1057-1062. PubMed ID: 33712477
[TBL] [Abstract][Full Text] [Related]
9. Periocular Skin Cancer in Solid Organ Transplant Recipients.
Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
[TBL] [Abstract][Full Text] [Related]
10. Report on the incidence of squamous cell carcinomas affecting the eyelids in England over a 15-year period (2000-2014).
Wawrzynski J; Tudge I; Fitzgerald E; Collin R; Desai P; Emeriewen K; Saleh GM
Br J Ophthalmol; 2018 Oct; 102(10):1358-1361. PubMed ID: 29363533
[TBL] [Abstract][Full Text] [Related]
11. The Australian Mohs database: periocular squamous cell carcinoma.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):617-23. PubMed ID: 15051191
[TBL] [Abstract][Full Text] [Related]
12. Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.
Hsia Y; Yeh CY; Wei YH; Chen LW; Liao SL
Eye (Lond); 2019 Jun; 33(6):887-895. PubMed ID: 31147618
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
[TBL] [Abstract][Full Text] [Related]
14. Periocular Squamous Cell Carcinoma: TNM Staging and Recurrence.
Sun MT; Andrew NH; O'Donnell B; McNab A; Huilgol SC; Selva D
Ophthalmology; 2015 Jul; 122(7):1512-6. PubMed ID: 25972255
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.
Jerjes W; Upile T; Petrie A; Riskalla A; Hamdoon Z; Vourvachis M; Karavidas K; Jay A; Sandison A; Thomas GJ; Kalavrezos N; Hopper C
Head Neck Oncol; 2010 Apr; 2():9. PubMed ID: 20406474
[TBL] [Abstract][Full Text] [Related]
16. Contemporary update of overall prognosis and nomogram to predict individualized survival for Chinese patients with eyelid sebaceous carcinoma.
Zhou C; Shi Y; Chai P; Wu F; Xia W; He X; Shi Y; Huang H; Jia R; Fan X
EBioMedicine; 2018 Oct; 36():221-228. PubMed ID: 30236450
[TBL] [Abstract][Full Text] [Related]
17. Higher Ki67 Index, Nodal Involvement, and Invasive Growth Were High Risk Factors for Worse Prognosis in Conventional Mammary Analogue Secretory Carcinoma.
Sun J; Wang L; Tian Z; Hu Y; Xia R; Li J
J Oral Maxillofac Surg; 2019 Jun; 77(6):1187-1202. PubMed ID: 30779892
[TBL] [Abstract][Full Text] [Related]
18. Impact of anatomic origin of primary squamous cell carcinomas of the nasal cavity and ethmoidal sinus on clinical outcome.
Janik S; Gramberger M; Kadletz L; Pammer J; Grasl MC; Erovic BM
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2363-2371. PubMed ID: 30027439
[TBL] [Abstract][Full Text] [Related]
19. Eyelid sebaceous gland carcinoma: An assessment of the T classification of the American Joint Committee of Cancer TNM staging system 8th versus 7th edition.
AlHammad F; Edward DP; Alkatan HM; Elkhamary S; Iuliano A; Maktabi A; Al-Horani SE; Al-Sheikh O; Al Hussain H; Strianese D
Eur J Ophthalmol; 2021 Jul; 31(4):2055-2063. PubMed ID: 32567368
[TBL] [Abstract][Full Text] [Related]
20. Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma.
Sagiv O; Nagarajan P; Ferrarotto R; Kandl TJ; Thakar SD; Glisson BS; Altan M; Esmaeli B
Br J Ophthalmol; 2019 Jun; 103(6):775-780. PubMed ID: 30021814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
